| |
| | Bismuth compounds for the treatment and prevention of mucositis - US Patent 6565895 (Site not responding. Last check: 2007-10-03) |
 | | In a preferred embodiment, the bismuth compound is an organic or inorganic salt such as, bismuth subsalicylate, bismuth subgallate, bismuth aluminate, bismuth citrate, bismuth subcitrate, bismuth carbonate, bismuth subcarbonate, tripotassium dicitrato bismuthate, bismuth nitrate, bismuth subnitrate, bismuth tartrate and mixtures thereof, preferably, bismuth subsalicylate and bismuth subgallate. |
 | | The method of claim 3 wherein the bismuth salt is a mixed salt of a non-steroidal anti-inflammatory agent and an antioxidant or a free radical scavenger. |
 | | In another preferred embodiment, the bismuth compound is the salt of an amino acid or a peptide, preferably an antimicrobial peptide (e.g., maganin, cecoropin and iseganin). |
| www.patentstorm.us /patents/6565895.html (4856 words) |
|